Â鶹app

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Â鶹app - Outstanding Awards (Details)

v3.23.1
Stock-Based Compensation - Â鶹app - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Additional disclosures Ìý
Total unrecognized compensation cost related to unvested equity awards | $ $ 35
Weighted average period of recognition related to unvested equity awards (in years) 1 year 2 months 12 days
Â鶹app SiriusXM Group Ìý
Additional disclosures Ìý
Common stock reserved for issuance 6,000,000.0
Â鶹app SiriusXM Group | Common Class A Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Â鶹app SiriusXM Group | Common Class B Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Â鶹app SiriusXM Group | Series C Ìý
Number of options Ìý
Outstanding at beginning of period 6,862,000
Granted 370,000
Exercised (213,000)
Forfeited/Cancelled (980,000)
Outstanding at end of period 6,039,000
Exercisable at end of period 3,722,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 39.83
Granted | $ / shares 31.19
Exercised | $ / shares 32.61
Forfeited/Cancelled | $ / shares 31.33
Outstanding at end of period | $ / shares 40.94
Exercisable at end of period | $ / shares $ 39.97
Additional disclosures Ìý
Weighted average remaining life, outstanding 3 years 4 months 24 days
Weighted average remaining life, exercisable 2 years 7 months 6 days
Formula One Group Ìý
Additional disclosures Ìý
Common stock reserved for issuance 6,500,000
Formula One Group | Common Class A Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Formula One Group | Common Class B Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Formula One Group | Series C Ìý
Number of options Ìý
Outstanding at beginning of period 7,086,000
Granted 71,000
Exercised (669,000)
Outstanding at end of period 6,488,000
Exercisable at end of period 5,002,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 36.18
Granted | $ / shares 75.12
Exercised | $ / shares 29.06
Outstanding at end of period | $ / shares 37.34
Exercisable at end of period | $ / shares $ 35.08
Additional disclosures Ìý
Weighted average remaining life, outstanding 3 years 8 months 12 days
Weighted average remaining life, exercisable 3 years 6 months
Aggregate intrinsic value, outstanding | $ $ 243
Aggregate intrinsic value, exercisable | $ $ 199
Braves Group Ìý
Additional disclosures Ìý
Common stock reserved for issuance 3,000,000.0
Braves Group | Common Class A Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Braves Group | Common Class B Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Braves Group | Series C Ìý
Number of options Ìý
Outstanding at beginning of period 3,108,000
Exercised (146,000)
Forfeited/Cancelled (4,000)
Outstanding at end of period 2,958,000
Exercisable at end of period 1,357,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 26.17
Exercised | $ / shares 18.32
Forfeited/Cancelled | $ / shares 22.75
Outstanding at end of period | $ / shares 26.57
Exercisable at end of period | $ / shares $ 25.68
Additional disclosures Ìý
Weighted average remaining life, outstanding 4 years 3 months 18 days
Weighted average remaining life, exercisable 4 years 1 month 6 days
Aggregate intrinsic value, outstanding | $ $ 21
Aggregate intrinsic value, exercisable | $ $ 11